Laman UtamaABCL • NASDAQ
add
AbCellera Biologics Inc
Tutup sebelumnya
$4.87
Julat hari
$4.67 - $4.92
Julat tahun
$1.89 - $6.52
Permodalan pasaran
1.42B USD
Bilangan Purata
5.39J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 17.08J | 133.29% |
Perbelanjaan pengendalian | 27.46J | -54.13% |
Pendapatan bersih | -34.73J | 5.97% |
Margin untung bersih | -203.27 | 59.69% |
Pendapatan bagi setiap syer | -0.12 | 7.69% |
EBITDA | -44.11J | 22.51% |
Kadar cukai berkesan | 4.45% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 553.08J | -17.49% |
Jumlah aset | 1.40B | -0.74% |
Jumlah liabiliti | 394.98J | 31.00% |
Jumlah ekuiti | 1.01B | — |
Syer tertunggak | 298.83J | — |
Harga kepada buku | 1.43 | — |
Pulangan pada aset | -9.03% | — |
Pulangan pada modal | -11.07% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -34.73J | 5.97% |
Tunai daripada operasi | -32.40J | -8.14% |
Tunai daripada pelaburan | -31.81J | -161.06% |
Tunai daripada pembiayaan | -3.38J | -227.31% |
Perubahan bersih dalam tunai | -66.83J | -370.13% |
Aliran tunai bebas | -61.07J | -43.54% |
Perihal
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Diasaskan
2012
Ibu pejabat
Tapak web
Pekerja
596
